News May 13, 2024 Canton of Zug funds institute for blockchain research The canton of Zug is contributing to the costs of setting up an institute for blockchain research. The project of the University of Lucerne and L...
News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News Mar 26, 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News Aug 23, 2023 Forty51 Ventures provides the financial backing to found Mysthera Therapeutics Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also based in Basel, has provided 3.5 million US dol...
News Feb 29, 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
News Mar 01, 2024 Idorsia enters collaboration with Viatris The biotech company Idorsia from the canton of Basel-Landschaft and the North American pharmaceutical company Viatris are collaborating on the de...
News Apr 18, 2023 The Crypto Explorer Podcast: The Financial and Banking Environment Around Crypto This episode is part of a limited podcast series produced in partnership with Home of Blockchain.swiss and Sygnum. In four episodes, we explore h...
News Dec 12, 2023 PharmaBiome and Ferring agree cooperation PharmaBiome and the biopharmaceutical firm Ferring from the canton of Vaud will in future each jointly develop and manufacture specific bacterial...
News Dec 08, 2023 Lugano gastronomy business mines bitcoin while baking The food and hospitality company Gabbani has integrated a bitcoin mining system into its production facility, which is powered using the business...
News Oct 25, 2023 Pyrpose’s finance platform bridges gap between consumers and climate innovators Geneva’s climate finance innovator, Pyrpose, takes another significant stride by launching its platform to the public, providing direct access fo...
News Jun 15, 2023 Zug destined to become a blockchain research center Crypto Valley in the canton of Zug is being developed as an international center for blockchain research. The cantonal government of Zug is to co...
News Nov 06, 2023 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News Jun 13, 2023 Merck unveils its cutting-edge Biotech Development Center in Corsier-sur-Vevey German pharmaceutical giant Merck has celebrated the inauguration of its state-of-the-art Biotech Development Center in Corsier-sur-Vevey.
News Oct 19, 2023 Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment Biel-based Mimix Biotherapeutics announced the closure of a significant investment round, drawing participation from both European and Asian inve...
News Oct 17, 2023 Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund Vaud-based start-ups Voltiris, Limula, and Parithera gain momentum in their innovative ventures as they secure vital funding and support from Bio...
News Oct 16, 2023 Adiposs completes the phase I clinical trial of its flagship product ImageBAT Geneva-based biotech Adiposs casts a ray of hope onto the horizons of cancer treatment and patient care with the successful conclusion of the Pha...
News Aug 02, 2023 Neuchâtel: the new Swiss crypto haven At the heart of Western Switzerland, a revolution is quietly brewing. Where most would expect the bustling financial hubs of Geneva or Zug to spe...